Presence Hallucination in Parkinson's Disease

NCT04579887 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-10-08

No results posted yet for this study

Summary

Investigation on how robotically mediated sensorimotor stimulation induces and triggers presence hallucinations in patients with Parkinson disease

Conditions

  • Parkinson Disease Psychosis

Interventions

OTHER

Brain changes triggered by PH induction in Parkinson's disease patients with presence hallucinations

Parkinsonian patients will undergo a two distinct experimental sessions, conducted in two separate days. In day 1, they will complete a series of validated and lab-tailored clinical evaluations, alongside with semi-structured interviews. These tests are designed to assess, the extent of the movement disorder, the predominance of positive symptoms and presence hallucination, potential cognitive impairment, amongst other relevant measures, for sleep assessment, loneliness, apathy and depression. In day 2 patients will perform the described robotic manipulation task in the MRI.

Sponsors & Collaborators

  • University Hospital, Geneva

    collaborator OTHER
  • Centre Hospitalier Universitaire Vaudois

    collaborator OTHER
  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER
  • Hôpital du Valais

    collaborator OTHER
  • Olaf Blanke

    lead OTHER

Principal Investigators

  • Olaf Blanke · Ecole Polytechnique Fédérale de Lausanne

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-17
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04579887 on ClinicalTrials.gov